Page last updated: 2024-11-04

gatifloxacin and Apoplexy

gatifloxacin has been researched along with Apoplexy in 2 studies

Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cannon, CP2
Braunwald, E2
McCabe, CH1
Grayston, JT1
Muhlestein, B1
Giugliano, RP1
Cairns, R2
Skene, AM1
Mega, JL1
Morrow, DA1
Murphy, S1
Ridker, PM1

Trials

2 trials available for gatifloxacin and Apoplexy

ArticleYear
Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome.
    The New England journal of medicine, 2005, Apr-21, Volume: 352, Issue:16

    Topics: Aged; Angina, Unstable; Anti-Bacterial Agents; Cardiovascular Diseases; Chlamydophila Infections; Ch

2005
Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapy.
    Journal of thrombosis and thrombolysis, 2006, Volume: 22, Issue:1

    Topics: Aged; Angina, Unstable; Atorvastatin; C-Reactive Protein; Cholesterol; Epidemiologic Methods; Female

2006